Back
Novonesis AS Quote, Financials, Valuation and Earnings
Sponsored
NVZMY
Sponsored
This trade could move overnight Thursday!
Access my free presentation on these overnight trades right here
Sell
45
NVZMY
Novonesis AS
Last Price:
55.06
Seasonality Move:
4.56%
7 Day Trial
ALL ACCESS PASS
$
7
America's Final Republican President
Click here to see his 2024 election prediction.Novonesis AS Price Quote
$55.06
-0.07 (-0.13%)
(Updated: May 1, 2024 at 4:10 PM ET)
Novonesis AS Key Stats
Sell
45
Novonesis AS (NVZMY)
is a Sell
Day range:
$55.13 - $56.28
52-week range:
$38.75 - $61.86
Dividend yield:
2.62%
P/E ratio:
34.90
P/S ratio:
5.90
P/B ratio:
12.34%
Volume:
6.8K
Avg. volume:
10.1K
1-year change:
6.02%
Market cap:
$25.6B
Revenue:
$2.6B
EPS:
$1.58
How Much Does Novonesis AS Make?
-
How Much Are Novonesis AS's Sales Annually?
NVZMY Revenues are $2.6B -
How Much Profit Does Novonesis AS's Make A Year?
NVZMY net income is $439M
Is Novonesis AS Growing As A Company?
-
What Is Novonesis AS's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.07% -
What Is Novonesis AS's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is -0.17%
Novonesis AS Stock Price Performance
-
Did Novonesis AS Stock Go Up Last Month?
Novonesis AS share price went down by -6.34% last month -
Did NVZMY's Share Price Rise Over The Last Year?
NVZMY share price rose by 6.02% over the past 1 year
What Is Novonesis AS 52-Week High & Low?
-
What Is Novonesis AS’s 52-Week High Share Price?
Novonesis AS has traded as high as $61.86 over the past 52 weeks -
What Is Novonesis AS’s 52-Week Low Share Price?
Novonesis AS has traded as low as $38.75 over the past 52 weeks
Novonesis AS Price To Free Cash Flow
-
Is Novonesis AS Stock Overvalued?
Novonesis AS is trading at a price to free cash flow ratio of 50.35 -
Is Novonesis AS Stock Undervalued?
Novonesis AS EV to Free Cash Flow ratio is 87.34 -
What Is Novonesis AS’s Price Earnings Growth Ratio?
NVZMY PEG ratio is 0.00 -
Is Novonesis AS Trading At A Premium To Earnings?
Novonesis AS EV to EBIT ratio is 42.96
Is It Risky To Buy Novonesis AS?
-
How Much Debt Does Novonesis AS Have?
Total long term debt quarterly is $1.1B -
How Much Cash Does Novonesis AS Have?
Cash and short term investments quarterly total is $171.6M -
What Is Novonesis AS’s Book Value Per Share?
Book value per share is 7.48
Is Novonesis AS Cash Flow Positive?
-
What Is NVZMY Cash Flow From Operations?
Cash flow from operations (TTM) is $602.8M -
What Is Novonesis AS’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$274.3M -
What Is Novonesis AS’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$309.7M
Novonesis AS Return On Invested Capital
-
Is Management Doing A Good Job?
NVZMY return on invested capital is 17.9% -
What Is Novonesis AS Return On Assets?
ROA measures how assets are converting to revenues and is 10.69% -
What Is NVZMY Return On Equity?
ROE is a measure of profitability and is 21.43%
Novonesis AS Earnings Date & Stock Price
-
What Is Novonesis AS's Stock Price Today?
A single share of NVZMY can be purchased today for 55.13 -
What Is Novonesis AS’s Stock Symbol?
Novonesis AS trades on the otcm under the ticker symbol: NVZMY -
When Is Novonesis AS’s Next Earnings Date?
The next quarterly earnings date for Novonesis AS is scheduled on May 3, 2024 -
When Is NVZMY's next ex-dividend date?
Novonesis AS's next ex-dividend date is May 1, 2024 -
How To Buy Novonesis AS Stock?
You can buy Novonesis AS shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Novonesis AS Competitors
-
Who Are Novonesis AS's Competitors?
Below is a list of companies who compete with Novonesis AS or are related in some way:
Novonesis AS Dividend Yield
-
What Is NVZMY Dividend Yield?
Novonesis AS’s dividend yield currently is 2.62% -
What Is Novonesis AS’s Payout Ratio?
Novonesis AS’s payout ratio is 94.44% -
When Did Novonesis AS Last Pay A Dividend?
The latest dividend pay date is May 1, 2024 -
What Is Novonesis AS’s Dividend Per Share?
Novonesis AS pays a dividend of $0.60 per share
Novonesis AS Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | -17.14% | 0% |
Revenue: | 6.7% | 0% |
Analyst Recommendations
Buy Recommendations: | 0 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 0.00 |
Downside from Last Price: | -100% |